Basic Information
ID: ALA3222808
Type: Binding
Description: Antagonist activity against human GPR18 expressed in CHO cells assessed as reduction in delta9-THC-induced beta-arrestin recruitment at 10 uM by beta-galactosidase enzyme fragment complementation method
Format: BAO_0000219
Organism: Homo sapiens
Cell type: CHO
Target: N-arachidonyl glycine receptor(ALA2384898)
Document: ALA3217528
Antagonist activity against human GPR18 expressed in CHO cells assessed as reduction in delta9-THC-induced beta-arrestin recruitment at 10 uM by beta-galactosidase enzyme fragment complementation method: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3222808
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 361.53 | 5.33 | 5.33 |
| 272.37 | 3.14 | 3.14 |
| 294.38 | 2.88 | 2.88 |
| 366.44 | 2.81 | 2.81 |
| 294.38 | 2.88 | 2.88 |
| 366.44 | 2.81 | 2.81 |
| 308.41 | 3.27 | 3.27 |
| 308.41 | 3.27 | 3.27 |
| 322.43 | 3.66 | 3.66 |
| 322.43 | 3.66 | 3.66 |
| 262.31 | 2.50 | 2.50 |
| 280.30 | 2.64 | 2.64 |
| 280.30 | 2.64 | 2.64 |
| 323.22 | 3.13 | 3.13 |
| 289.32 | 2.27 | 2.27 |
| 289.32 | 2.27 | 2.27 |
| 274.35 | 2.37 | 2.37 |
| 274.35 | 2.37 | 2.37 |
| 304.37 | 2.38 | 2.38 |
| 304.37 | 2.38 | 2.38 |
| 304.37 | 2.38 | 2.38 |
| 286.40 | 3.49 | 3.49 |
| 287.39 | 2.43 | 2.43 |
| 336.42 | 4.15 | 4.15 |
| 270.36 | 2.92 | 2.92 |
| 270.36 | 2.92 | 2.92 |
| 334.44 | 4.42 | 4.42 |
| 364.47 | 4.33 | 4.33 |
| 398.92 | 4.99 | 4.99 |
| 398.92 | 4.99 | 4.99 |
| 382.46 | 4.47 | 4.47 |
| 360.44 | 2.69 | 2.69 |
| 620.67 | 2.36 | 2.36 |
| 244.32 | 2.36 | 2.36 |
| 278.76 | 3.02 | 3.02 |
| 278.76 | 3.02 | 3.02 |
| 278.76 | 3.02 | 3.02 |
| 313.21 | 3.67 | 3.67 |
| 313.21 | 3.67 | 3.67 |
| 313.21 | 3.67 | 3.67 |